Proxy Materials

You will find our proxy statement and our Annual Report on Form 10-K below. After reviewing these materials, if you are a registered holder of shares of Innoviva, Inc., you may vote your shares via the internet at https://www.proxyvotenow.com/inva or on the telephone by calling 1-888-216-1318. In order to vote, you will need to have in-hand information from your proxy card that will be mailed to you, along with the Annual Report and proxy statement, on or around March 22, 2017. If you are a beneficial holder of shares of Innoviva (for example, your shares are held in an account at an institution such as a brokerage firm, bank, dealer, or other similar organization), please follow the voting instructions provided by your institution.

Innoviva Letter to Investors, April 17, 2017
Download PDF

13D Filing: GSK intends to vote for Innoviva's Board of Director nominees at the 2017 Annual Meeting, April 13, 2017
View HTML

Press Release - Innoviva to Undertake Comprehensive Review of Cost and Executive Compensation Structures, April 13, 2017
Download PDF

Innoviva Letter to Investors, April 12, 2017
Download PDF

Corporate Presentation, April 3, 2017
Download PDF

Innoviva Letter to Investors, April 3, 2017
Download PDF

Innoviva Letter to Investors, March 29, 2017
Download PDF

Corporate Presentation, March 28, 2017
Download PDF

Innoviva Letter to Investors, March 21, 2017
Download PDF

Innoviva Proxy Statement
View HTML
Download PDF

Innoviva Form 10-K
View HTML
Download PDF  [748 KB]

Innoviva NASDAQ: INVA

$11.79 0.81 (6.39%) 04/28/17 4:15 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.